July 2007 Issue of MMM
I always look forward to compiling the July issue because, although we cover agency news year-round, it affords us a much more detailed look at ...
The indispensable guide to healthcare agencies, including contact details, rosters, wins, losses and examples of creative work. Firms submitted their own data as part of ...
Your at-a-glance guide to which agencies hold the professional and consumer accounts on the top 20 prescription drug brands by US sales
HCB is following an ambition bigger than Texas, Carbon is winning bags of big-name business and The Navicor Group is collecting clients through its commitment ...
Successful beyond its wildest dreams (even the one with Abe and the beaver)
J&J brands help rebuild momentum following the president’s departure
CDM splinter is off to an explosive start, propelled by Novartis work
Two-year-old specialty shop boosted by significant growth in global work
Finding life after Nelson, and ready to ramp up its digital offerings
Continued growth explosion from an influx of new interactive business
Third consecutive year of 20% growth rewards global vision and creativity
A bigfoot firm steps out, finds competition liberating—and lucrative
Columbia-Walsh leads the restructured group to greater scope and expertise
Investing the kind of talent that will support 45 more years of success
The former MBC agency thrives on the support of its new parent
Midwest mainstay continues to expand geographically and therapeutically
Well-placed for global growth after acquisition by British powerhouse
Continued upswing from organic growth and a wealth of additional resources at its disposal
Improved management structure returns notable organic growth
Astronomical growth from a trio of new GlaxoSmithKline accounts
Ready to seek new clients, following a year of significant organic growth
Euro RSCG Life LM&P is a great story right now, according to agency president David Paragamian
Winning pitches with its new, flat management structure in place
Returning to its roots revitalizes CommonHealth’s original shop
Celebrated its 25th birthday with 20% growth and a cruise to the Bahamas
Ringing the changes with a structural overhaul and a new media fascination
Settled quickly at head of the inVentiv table with a remarkable display of creativity and growth
Employee initiatives readies ranks for global, interactive business push
Innovative shop performs even more impressively on a bigger stage
After a five-year hot streak, ICC gets Alchemy to spur further growth
Wins from Pfizer and BMS, and its first foray into DTC, add up to a solid year
Multi-channel mindset maintains lofty position for young agency of record
San Francisco shop pauses for breath after a decade of explosive growth
Currently regrouping, following the departure of CEO Stu Klein
Steady growth on both coasts helped offset the significant loss of Allergan
Continuing focus on integrating digital offerings and attracting talented staff
Publicis specialist shop overcomes Ketek setback with spate of wins
A recent rebranding gives birth to an agency that promises a cure for complacency
Added Chantix and Cervarix to a long list of big-name consumer accounts
Bolstered by new business, the firm continues to extend its global reach
Holistic approach pays with a ton of new business; staff grows by 50%
On a crusade to break the mold of industry stagnation and boring ads
By expanding its integrated offerings, demonstrating ROI and filling in gaps in global reach, the giant is in good health
Perreca oversees recovery from loss of its CEO and a key Pfizer franchise
Revenues and staffing levels continue to rise in a difficult West Coast market
Organic growth makes up for losses from GSK's agency consolidation
GSKs Avandia and Coreg represent RCWs first foray into primary care
New management structure steers this formidable alliance of professional and consumer capabilities
After a management restructure and a solid home performance, SH takes on the world
Living up to its name with spectacular growth from a glut of new business
Pedigree shop propelled further by the GlaxoSmithKline consolidation
Despite wins, outside forces converge on two key clients to flatten revenues
Slightly down overall, but the agency rallied to make up for med ed losses
Won 80% of its pitches in a year that marked its first venture into DTC
Marketing guru Seth Godin has done it again. Each year, he publishes a book, examining marketing from a whole new perspective, and then spends the ...
When Rezulin was removed from the market several years ago, the top endocrinologist I worked with was quite upset.
Med Ed Report
The tragic shootings at Virginia Polytechnic Institute and State University in April underscored the need for education on diagnosing and treating mental health problems.
Joseph Green, PhD, will join the American College of Cardiology (ACC) in September as VP for professional development and chief learning officer, marking his return ...
Haymarket has named Dik Barsamian EVP in charge of medical education.
The publisher of the BMJ has formed a partnership with Johns Hopkins School of Medicine to jointly develop CME.
Linda Raichle, PhD, MS, former director of external affairs for Merck, has formed a new med ed company, Spectrum Medical Education.
A new Web site, ContinuingEducationLinks.com, provides a national database of on-site and online CE courses, searchable by geographical location and occupation.
The American Medical Association (AMA) announced it is partnering with Sermo, the online community for physicians.
Wolters Kluwer is launching The Patient, a quarterly journal that will look at reimbursement issues from a patient perspective.
Ascend Healthcare Media hired VNU's Gary Gyss to serve as publisher of The American Journal of Managed Care.
Journal Watch, an online digest of medical journal articles, responded to reader criticism of its disclosure policy by reducing the number of click-throughs required to ...
The American College of Cardiology's Board of Trustees approved sanctions against a physician for leaks that broke an embargo on COURAGE trial data presented at ...
JAMA is launching a weekly French-language online journal, JAMA-Francais, and hosting a conference for Parisian physicians comparing the new French CME regime to the US ...
Doctors are people, too. So much so that they’re flocking to a Web “chat room” just for them. Perhaps “chat room” is a misnomer.
Consumers’ online health search behavior differs significantly based on their stage of illness and the condition they are seeking information on, a new study from ...
Microsoft agreed to buy digital marketing firm aQuantive in a deal valued at $6 billion.
Over 80% of brand managers believe an integrated direct marketing program is an important part of promoting a brand, with almost half saying it is ...
The FDA’s Division of Drug Marketing, Advertising and Communications has issued untitled letters of violation to Schering-Plough for its Nasonex nasal spray, and to GlaxoSmithKline ...
Bradley Pharmaceuticals is hiring about 60 reps as it gears up to launch Elestrin, a low-dose estrogen gel for treating the symptoms of menopause.
Nancy Connelly was named SVP, sales support services at contract sales provider PDI.
Ingrid Swan was named VP, general manager of MediZine.
Four ex-Serono execs, who were linked to alleged illegal kickbacks, were acquitted in May of any role they allegedly played in illegally boosting sales for ...
Redi-Mail Direct Marketing has received Verified Accredited Wholesale Distributors accreditation status from the National Association of Boards of Pharmacy.
Consumers are getting savvier about the risks and benefits of the medicines they’re taking, according to Prevention’s 10th Annual National Survey on Consumer Reaction to ...
PhRMA’s Office of Accountability released its second survey of comments received by companies regarding DTC ads, which showed concern among consumers and physicians about the ...
Eli Lilly is drawing the line on DTC—at the spots plugging the services of ambulance-chasing trial lawyers.
Members of the FDA’s Oncologic Drugs Advisory Committee expressed concerns at a May meeting that DTC advertising of Amgen’s Aranesp and Johnson & Johnson’s Procrit ...
Lunesta ads remain the best-recalled on TV, according to IAG Research, but now have some company in the sleep category.
A consortium of pharmas want to launch a European health info channel, The Guardian reports.
I sat in a meeting recently listening to two agencies bicker about which will shrivel up first in the next decade—advertising or PR.
On the eve of the June 29 debut of Sicko, Michael Moore’s broadside against American healthcare, pharma communicators were wary but optimistic that his latest ...
Former Euro RSCG Life PR head David Catlett has resurfaced as head of GolinHarris’ New York healthcare practice.
Pharma brand share can level off just a few short months after a launch, according to a new study from IMS Health that examines this ...
Financial analysts, known for their penchant to wield prescribing data, may have jumped the gun recently.
The FDA's own little "Avandiagate," complete with Nixonian "dirty tricks," emerged in May's mass media coverage of the editorial decision at the New England Journal ...
While acknowledging improvements in the guidance they get from the FDA, the nation’s pharmaceutical, biotechnology, and medical device companies still want faster turnaround times and ...
The Purdue Frederick Co. and three of its officers entered a plea agreement with the FDA in which the company agreed to pay more than ...
What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.
A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.